WO2002036591A3 - Inhalative lösungsformulierung mit einem tiotropiumsalz - Google Patents
Inhalative lösungsformulierung mit einem tiotropiumsalz Download PDFInfo
- Publication number
- WO2002036591A3 WO2002036591A3 PCT/EP2001/012296 EP0112296W WO0236591A3 WO 2002036591 A3 WO2002036591 A3 WO 2002036591A3 EP 0112296 W EP0112296 W EP 0112296W WO 0236591 A3 WO0236591 A3 WO 0236591A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- formulation containing
- solution formulation
- tiotropium salt
- inhalative solution
- inhalative
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000009472 formulation Methods 0.000 title abstract 2
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 2
- LERNTVKEWCAPOY-VOGVJGKGSA-N C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 Chemical compound C[N+]1(C)[C@H]2C[C@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 LERNTVKEWCAPOY-VOGVJGKGSA-N 0.000 abstract 1
- 239000000443 aerosol Substances 0.000 abstract 1
- 229960000257 tiotropium bromide Drugs 0.000 abstract 1
- MQLXPRBEAHBZTK-SEINRUQRSA-M tiotropium bromide hydrate Chemical compound O.[Br-].C[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)C(O)(c1cccs1)c1cccs1 MQLXPRBEAHBZTK-SEINRUQRSA-M 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Dispersion Chemistry (AREA)
- Otolaryngology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (22)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MEP-2008-407A ME00242B (de) | 2000-10-31 | 2001-10-24 | Inhalative lösungsformulierung mit einem tiotropiumsalz |
IL15567601A IL155676A0 (en) | 2000-10-31 | 2001-10-24 | Inhalative solution formulation containing a tiotropium salt |
KR1020037006001A KR100983208B1 (ko) | 2000-10-31 | 2001-10-24 | 티오트로퓸 염을 함유하는 용액의 흡입성 제형 |
MXPA03003750A MXPA03003750A (es) | 2000-10-31 | 2001-10-24 | Formulacion de una solucion de inhalacion con una sal de tiotropio. |
BR0115016-2A BR0115016A (pt) | 2000-10-31 | 2001-10-24 | Formulação de solução inalativa com um sal de tiotrópio |
UA2003054960A UA76435C2 (en) | 2000-10-31 | 2001-10-24 | Inhalation formulation of tiotropium salt |
AU2174102A AU2174102A (en) | 2000-10-31 | 2001-10-24 | Inhalative solution formulation containing a tiotropium salt |
EP01992710A EP1335729A2 (de) | 2000-10-31 | 2001-10-24 | Inhalative lösungsformulierung mit einem tiotropiumsalz |
CA002427583A CA2427583C (en) | 2000-10-31 | 2001-10-24 | Inhalable formulation of a solution containing a tiotropium salt |
HU0301377A HUP0301377A3 (en) | 2000-10-31 | 2001-10-24 | Combination pharmaceutical composition in form of inhalative solution containing a tiotropium salt |
PL01361001A PL361001A1 (en) | 2000-10-31 | 2001-10-24 | Inhalative solution formulation containing a tiotropium salt |
EA200300483A EA009068B1 (ru) | 2000-10-31 | 2001-10-24 | Ингаляционная композиция в виде раствора с солью тиотропия |
EEP200300202A EE05343B1 (et) | 2000-10-31 | 2001-10-24 | Tiotroopiumsoola sisaldav inhaleeritav lahusekompositsioon |
AU2002221741A AU2002221741B2 (en) | 2000-10-31 | 2001-10-24 | Inhalative solution formulation containing a tiotropium salt |
JP2002539350A JP4559703B2 (ja) | 2000-10-31 | 2001-10-24 | チオトロピウム塩を含有する溶液の吸入組成物 |
NZ526024A NZ526024A (en) | 2000-10-31 | 2001-10-24 | Inhalative propellant-free solution formulation containing a tiotropium salt |
SK526-2003A SK288031B6 (sk) | 2000-10-31 | 2001-10-24 | Propellant-free liquid inhalation formulation |
BG107726A BG66425B1 (bg) | 2000-10-31 | 2003-04-16 | Препарат като инхалационен разтвор, съдържащ тиотропиева сол |
HR20030337A HRP20030337A2 (en) | 2000-10-31 | 2003-04-28 | Inhalative solution formulation containing a tiotropium salt |
NO20031914A NO332524B1 (no) | 2000-10-31 | 2003-04-29 | Inhalerbar losningsformulering inneholdende et tiotropiumsalt, slike preparater for anvendelse som medikament samt anvendelse av slike for fremstilling av medikament for behandling av sykdom |
IL155676A IL155676A (en) | 2000-10-31 | 2003-04-30 | Liquid pharmaceutical composition without propellant containing theotropium salt and other active substance and its use in the preparation of a drug for the treatment of asthma or COPD |
HK04103587A HK1060569A1 (en) | 2000-10-31 | 2004-05-20 | Inhalative solution formulation containing a tiotropium salt |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10054042 | 2000-10-31 | ||
DE10054042.2 | 2000-10-31 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002036591A2 WO2002036591A2 (de) | 2002-05-10 |
WO2002036591A3 true WO2002036591A3 (de) | 2002-07-25 |
Family
ID=7661727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/012296 WO2002036591A2 (de) | 2000-10-31 | 2001-10-24 | Inhalative lösungsformulierung mit einem tiotropiumsalz |
Country Status (33)
Country | Link |
---|---|
EP (1) | EP1335729A2 (de) |
JP (1) | JP4559703B2 (de) |
KR (1) | KR100983208B1 (de) |
CN (1) | CN1237970C (de) |
AR (1) | AR038765A1 (de) |
AU (2) | AU2002221741B2 (de) |
BG (1) | BG66425B1 (de) |
BR (1) | BR0115016A (de) |
CA (1) | CA2427583C (de) |
CZ (1) | CZ305033B6 (de) |
DE (1) | DE10152369A1 (de) |
EA (1) | EA009068B1 (de) |
EC (1) | ECSP034570A (de) |
EE (1) | EE05343B1 (de) |
HK (1) | HK1060569A1 (de) |
HR (1) | HRP20030337A2 (de) |
HU (1) | HUP0301377A3 (de) |
IL (2) | IL155676A0 (de) |
ME (1) | ME00242B (de) |
MX (1) | MXPA03003750A (de) |
MY (1) | MY132777A (de) |
NO (1) | NO332524B1 (de) |
NZ (1) | NZ526024A (de) |
PE (1) | PE20020518A1 (de) |
PL (1) | PL361001A1 (de) |
SA (1) | SA01220503B1 (de) |
SK (1) | SK288031B6 (de) |
TW (1) | TWI296934B (de) |
UA (1) | UA76435C2 (de) |
UY (1) | UY26991A1 (de) |
WO (1) | WO2002036591A2 (de) |
YU (1) | YU33103A (de) |
ZA (1) | ZA200303045B (de) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20070092334A (ko) | 2000-04-28 | 2007-09-12 | 코산 바이오사이언시즈, 인코포레이티드 | 폴리케타이드의 제조방법 |
US20030235538A1 (en) | 2002-04-09 | 2003-12-25 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Method for the administration of an anticholinergic by inhalation |
GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
CA2544733A1 (en) * | 2003-10-09 | 2005-04-21 | Inverseon, Inc. | Methods for treating diseases and conditions with inverse agonists and for screening for agents acting as inverse agonists |
SE0303269L (sv) * | 2003-12-03 | 2005-06-04 | Microdrug Ag | Medicinsk produkt |
SI1863476T1 (sl) * | 2005-03-16 | 2016-05-31 | Meda Pharma Gmbh & Co. Kg | Kombinacija antiholinergikov in antagonistov receptorja levkotriena za zdravljenje respiratornih bolezni |
CA2653744C (en) * | 2006-05-26 | 2018-01-16 | Dey, L.P. | Nebulizable compositions of quaternary ammonium muscarinic receptor antagonists |
CN100446770C (zh) * | 2007-01-10 | 2008-12-31 | 上海现代药物制剂工程研究中心有限公司 | 丙酸培氯米松水雾剂 |
TR200907237A2 (tr) * | 2009-09-23 | 2011-04-21 | Bi̇lgi̇ç Mahmut | Tiotropyum kuru toz kombinasyonu |
CN116196298A (zh) * | 2018-07-26 | 2023-06-02 | 四川海思科制药有限公司 | 一种含格隆铵盐的气雾剂药物组合物及其制备方法与应用 |
CN111936124A (zh) * | 2018-07-26 | 2020-11-13 | 四川海思科制药有限公司 | 一种含格隆铵盐及茚达特罗盐的气雾剂药物组合物及其制备方法与应用 |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0504112A2 (de) * | 1991-03-14 | 1992-09-16 | Ciba-Geigy Ag | Pharmazeutische Aerosolformulierungen |
DE4203306A1 (de) * | 1992-02-06 | 1993-08-12 | Ig Spruehtechnik Gmbh | Asthma oder pulmonal-aerosolzubereitungen mit lecithin |
WO1997046243A1 (en) * | 1996-06-04 | 1997-12-11 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
JPH10298107A (ja) * | 1997-04-25 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
WO2000007567A1 (de) * | 1998-08-04 | 2000-02-17 | Jago Research Ag | Medizinische aerosolformulierungen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2183001T3 (es) * | 1995-06-27 | 2003-03-16 | Boehringer Ingelheim Pharma | Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor. |
DE19653969A1 (de) * | 1996-12-20 | 1998-06-25 | Boehringer Ingelheim Kg | Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole |
DE19847968A1 (de) * | 1998-10-17 | 2000-04-20 | Boehringer Ingelheim Pharma | Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen |
-
2001
- 2001-10-24 KR KR1020037006001A patent/KR100983208B1/ko active IP Right Grant
- 2001-10-24 EE EEP200300202A patent/EE05343B1/xx unknown
- 2001-10-24 NZ NZ526024A patent/NZ526024A/en not_active IP Right Cessation
- 2001-10-24 YU YU33103A patent/YU33103A/sh unknown
- 2001-10-24 UA UA2003054960A patent/UA76435C2/uk unknown
- 2001-10-24 CA CA002427583A patent/CA2427583C/en not_active Expired - Fee Related
- 2001-10-24 JP JP2002539350A patent/JP4559703B2/ja not_active Expired - Lifetime
- 2001-10-24 HU HU0301377A patent/HUP0301377A3/hu unknown
- 2001-10-24 SK SK526-2003A patent/SK288031B6/sk not_active IP Right Cessation
- 2001-10-24 AU AU2002221741A patent/AU2002221741B2/en not_active Expired
- 2001-10-24 IL IL15567601A patent/IL155676A0/xx unknown
- 2001-10-24 PL PL01361001A patent/PL361001A1/xx not_active Application Discontinuation
- 2001-10-24 AU AU2174102A patent/AU2174102A/xx active Pending
- 2001-10-24 CN CNB018183271A patent/CN1237970C/zh not_active Expired - Lifetime
- 2001-10-24 MX MXPA03003750A patent/MXPA03003750A/es active IP Right Grant
- 2001-10-24 EA EA200300483A patent/EA009068B1/ru not_active IP Right Cessation
- 2001-10-24 CZ CZ2003-1487A patent/CZ305033B6/cs not_active IP Right Cessation
- 2001-10-24 ME MEP-2008-407A patent/ME00242B/de unknown
- 2001-10-24 WO PCT/EP2001/012296 patent/WO2002036591A2/de active IP Right Grant
- 2001-10-24 EP EP01992710A patent/EP1335729A2/de not_active Ceased
- 2001-10-24 DE DE10152369A patent/DE10152369A1/de not_active Withdrawn
- 2001-10-24 BR BR0115016-2A patent/BR0115016A/pt active Pending
- 2001-10-29 UY UY26991A patent/UY26991A1/es not_active Application Discontinuation
- 2001-10-29 PE PE2001001072A patent/PE20020518A1/es active IP Right Grant
- 2001-10-29 MY MYPI20014987A patent/MY132777A/en unknown
- 2001-10-29 TW TW090126752A patent/TWI296934B/zh not_active IP Right Cessation
- 2001-10-31 AR ARP010105088A patent/AR038765A1/es not_active Ceased/Invalidation/Refusal/Rejection/Nullification
- 2001-11-03 SA SA01220503A patent/SA01220503B1/ar unknown
-
2003
- 2003-04-16 BG BG107726A patent/BG66425B1/bg active Active
- 2003-04-17 ZA ZA200303045A patent/ZA200303045B/xx unknown
- 2003-04-28 HR HR20030337A patent/HRP20030337A2/hr not_active Application Discontinuation
- 2003-04-28 EC EC2003004570A patent/ECSP034570A/es unknown
- 2003-04-29 NO NO20031914A patent/NO332524B1/no not_active IP Right Cessation
- 2003-04-30 IL IL155676A patent/IL155676A/en active IP Right Grant
-
2004
- 2004-05-20 HK HK04103587A patent/HK1060569A1/xx not_active IP Right Cessation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0504112A2 (de) * | 1991-03-14 | 1992-09-16 | Ciba-Geigy Ag | Pharmazeutische Aerosolformulierungen |
DE4203306A1 (de) * | 1992-02-06 | 1993-08-12 | Ig Spruehtechnik Gmbh | Asthma oder pulmonal-aerosolzubereitungen mit lecithin |
US5824669A (en) * | 1996-03-22 | 1998-10-20 | Nitromed, Inc. | Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders |
WO1997046243A1 (en) * | 1996-06-04 | 1997-12-11 | The Procter & Gamble Company | A nasal spray containing an intranasal steroid and an antihistamine |
JPH10298107A (ja) * | 1997-04-25 | 1998-11-10 | Taisho Pharmaceut Co Ltd | 医薬組成物 |
WO2000007567A1 (de) * | 1998-08-04 | 2000-02-17 | Jago Research Ag | Medizinische aerosolformulierungen |
Non-Patent Citations (8)
Title |
---|
BALZANO G ET AL: "Effectiveness and acceptability of a domiciliary multidrug inhalation treatment in elderly patients with chronic airflow obstruction: metered dose inhaler versus jet nebulizer.", JOURNAL OF AEROSOL MEDICINE: THE OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY FOR AEROSOLS IN MEDICINE. UNITED STATES 2000 SPRING, vol. 13, no. 1, April 2000 (2000-04-01), pages 25 - 33, XP001078735, ISSN: 0894-2684 * |
MON F ET AL: "AEROSOL THERAPY IN ASTHMA", REVUE DES MALADIES RESPIRATOIRES, vol. 6, no. 3, 1989, pages 189 - 200, XP001078722, ISSN: 0761-8425 * |
NACLERIO R M: "Optimizing treatment options.", CLINICAL AND EXPERIMENTAL ALLERGY, vol. 28, no. SUPPL. 6, December 1998 (1998-12-01), pages 54 - 59, XP001078789, ISSN: 0954-7894 * |
NISHIMURA KOICHI ET AL: "Additive effect of oxitropium bromide in combination with inhaled corticosteroids in the treatment of elderly patients with chronic asthma.", ALLERGOLOGY INTERNATIONAL, vol. 48, no. 1, March 1999 (1999-03-01), pages 85 - 88, XP001070756, ISSN: 1323-8930 * |
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 02 26 February 1999 (1999-02-26) * |
PAVIA D ET AL: "Preliminary data from phase II studies with Respimat, a propellant-free soft mist inhaler.", JOURNAL OF AEROSOL MEDICINE: THE OFFICIAL JOURNAL OF THE INTERNATIONAL SOCIETY FOR AEROSOLS IN MEDICINE. UNITED STATES 1999, vol. 12 Suppl 1, 1999, pages S33 - S39, XP001078739, ISSN: 0894-2684 * |
RUTGERS S R ET AL: "Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.", AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. UNITED STATES MAR 1998, vol. 157, no. 3 Pt 1, March 1998 (1998-03-01), pages 880 - 886, XP001078742, ISSN: 1073-449X * |
VAN SCHAYCK C P ET AL: "Periodic treatment regimens with inhaled steroids in asthma or chronic obstructive pulmonary disease. Is it possible?", JAMA: THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION. UNITED STATES 12 JUL 1995, vol. 274, no. 2, 12 July 1995 (1995-07-12), pages 161 - 164, XP001078744, ISSN: 0098-7484 * |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002036591A3 (de) | Inhalative lösungsformulierung mit einem tiotropiumsalz | |
AP1572A (en) | Crystalline monohydrate, method for producing the same and use thereof in the production of a medicament. | |
RS76604A (en) | Pressuriesed metered dose inhalers containing solutions of beta-2 agonists | |
CA2359813A1 (en) | Nicotine mucosal spray | |
WO2007064658A3 (en) | Safe and effective methods of administering therapeutic agents | |
WO2007060104A3 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
AP2003002909A0 (en) | A PDE 4 inhibitor and an anti-cholinergic agent in combination for treating obstructive airways diseases. | |
WO2007060108A3 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
WO2005030211A8 (de) | Aerosolformulierung für die inhalation enthaltend ein anticholinergikum | |
WO2007137206A3 (en) | Unit dose formulations comprising an inhalable solution of albuterol | |
WO2002036104A3 (de) | Inhalative lösungsformulierung mit einem tiotropiumsalz | |
WO2000066107A3 (en) | Antimalarian agents for the treatment of asthma | |
IL195818A0 (en) | Derivatives of 2-benzoyl-imidazopyridines, preparation ,method thereof and use of same in therapeutics | |
MY137249A (en) | Aerosol formulation for inhalation containing a tiotropium salt | |
JP2003502361A5 (de) | ||
WO2005055717A3 (en) | Agrochemical compositions | |
WO2011077169A3 (en) | Pharmaceutical preparation comprising sufentanil | |
AU2003288107A1 (en) | Tiotropium-containing medicament combinations used for inhaling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 1200300391 Country of ref document: VN Ref document number: P-331/03 Country of ref document: YU |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
ENP | Entry into the national phase |
Ref document number: 10772601 Country of ref document: BG Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003/03045 Country of ref document: ZA Ref document number: 200303045 Country of ref document: ZA |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20030337A Country of ref document: HR Ref document number: PA/a/2003/003750 Country of ref document: MX Ref document number: 03035210 Country of ref document: CO |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1-2003-500304 Country of ref document: PH Ref document number: 018183271 Country of ref document: CN Ref document number: 2427583 Country of ref document: CA Ref document number: 5262003 Country of ref document: SK Ref document number: 2001992710 Country of ref document: EP Ref document number: 00649/DELNP/2003 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020037006001 Country of ref document: KR Ref document number: 2002539350 Country of ref document: JP Ref document number: 155676 Country of ref document: IL |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2002221741 Country of ref document: AU Ref document number: 200300483 Country of ref document: EA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 526024 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-1487 Country of ref document: CZ |
|
ENP | Entry into the national phase |
Ref document number: 20030802 Country of ref document: UZ Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: 2001992710 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-1487 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1020037006001 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 526024 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 526024 Country of ref document: NZ |
|
WWG | Wipo information: grant in national office |
Ref document number: 2002221741 Country of ref document: AU |